Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-062272
Filing Date
2010-12-16
Accepted
2010-12-16 17:31:20
Documents
1
Period of Report
2010-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd294546.html 4  
1 FORM 4 rrd294546.xml 4 4825
  Complete submission text file 0001181431-10-062272.txt   6804
Mailing Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Issuer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 9519 BROOKCHASE DRIVE RALEIGH NC 27617
Business Address
Severinghaus Carl (Reporting) CIK: 0001488364 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 101257746